Repligen (RGEN) Tops Q3 EPS by 9c. Updates Guidance
Tweet
Share
E-mailGet Alerts RGEN Hot Sheet
Price: $144.88 +0.44%
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
CCEL, MHGU, PLG, More
EPS Growth %: +21.6%
Financial Fact:
Cost of product revenue: 11.24M
Today's EPS Names:
CCEL, MHGU, PLG, More
Join SI Premium – FREE
Repligen (NASDAQ: RGEN) reported Q3 EPS of $0.77, $0.09 better than the analyst estimate of $0.68. Revenue for the quarter came in at $200.7 million versus the consensus estimate of $192.68 million.
GUIDANCE:
Repligen sees FY2022 EPS of $3.15-$3.20, versus the consensus of $3.20. Repligen sees FY2022 revenue of $795-805 million, versus the consensus of $804 million.
For earnings history and earnings-related data on Repligen (RGEN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Jefferies upgrades Shopify to Buy on AI commerce tailwinds, sees 30% upside
- Jefferies Upgrades Salzgitter AG (SZG:GR) (SZGPY) to Buy
- Sanuwave Q2 2026 revenue tops revised guidance range
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
